Hovione issues $50 million bond
Hovione has issued a bond of $50 million US dollars maturing in 2033.
Hovione has issued a bond of $50 million US dollars maturing in 2033.
‘One Site Shop’ expands to respond to growing demands
Hovione reported today recent capacity expansion and future plans in its sites in Portugal, Ireland and New Jersey.
Hovione announced today that in the last year their manufacturing facilities were the object of eight inspections, performed by different Health Authorities.
Hovione announces that it has concluded the sale of all of the share capital of iMAX Diagnostic Imaging limited.
Hovione announced that a new MG2 Tekna Precision Capsule filling unit is now online in its Portugal facilities
A Phase 2 Clinical Trial for the Treatment of Moderate to Severe Inflammatory Rosacea with its Proprietary Minocycline Topical Gel
Hovione announced today the appointment of Mr. Frédéric Kahn as Vice President Marketing and Sales, as of 1st September, 2017
HY02, a Proprietary Minocycline Sterile Ointment to Treat a Subset of Anterior Ocular Inflammation
Hovione announced today that it held on June 8th the official groundbreaking for the expansion of its New Jersey facility in East Windsor, USA